Topical Sirolimus Safe and Effective for Facial Angiofibromas in Tuberous Sclerosis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Efficacy and Safety of Topical Sirolimus Therapy for Facial Angiofibromas in the Tuberous Sclerosis Complex: A Randomized Clinical Trial
JAMA Dermatol 2016 Nov 12;[EPub Ahead of Print], M Wataya-Kaneda, A Nakamura, M Tanaka, M Hayashi, S Matsumoto, K Yamamoto, I KatayamaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.